GLAND PHARMA LIMITED : DISCLOSURE UNDER REGULATION 29(2) OF SEBI

• Sale of shares by Mirae Asset Mutual Fund on September 28, 2026. • Holding before sale: 49,30,033 shares (2.99% total voting capital, 2.96% diluted). • Holding after sale: 48,72,191 shares (2.95% total voting capital, 2.92% diluted). • Number of shares sold: 57,842. • Mode of sale: Open Market. • Total diluted share/voting capital of TC after the said sale: 16,68,08,368. Impact: Neutral (Routine disclosure of shareholding changes)

Gland Pharma Ltd

Open attachment

← Back to feed